United States · FDA National Drug Code directory
RECOMBIVAX HB
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-4995_32dbed7b-c62b-4294-8476-d134c8c1a6f4
- Product NDC
- 0006-4995
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- Hepatitis B Vaccine (Recombinant)
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 19860723
- Source listing expiry
- 20261231
Source-listed ingredients
- HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN — 10 ug/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4995-00) / 1 mL in 1 VIAL, SINGLE-DOSE (0006-4995-01) · 0006-4995-00
- 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4995-41) / 1 mL in 1 VIAL, SINGLE-DOSE (0006-4995-01) · 0006-4995-41
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →